Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Grows By 1,668.9%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the target of a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 17,636 shares, a growth of 1,668.9% from the July 30th total of 997 shares. Based on an average trading volume of 132,170 shares, the short-interest ratio is currently 0.1 days.

MediPharm Labs Stock Down 1.7%

MediPharm Labs stock traded down $0.00 during midday trading on Tuesday, hitting $0.06. 60,862 shares of the stock were exchanged, compared to its average volume of 81,835. The company has a fifty day simple moving average of $0.05 and a two-hundred day simple moving average of $0.05. MediPharm Labs has a 52 week low of $0.04 and a 52 week high of $0.08.

MediPharm Labs Company Profile

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.